Schedule 13D ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2023-10-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-257707
Form type
SC 13D/A
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Oct 17, 2023
Reporting period
Oct 16, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub